Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

J Virol. 1998 Jul;72(7):5648-53. doi: 10.1128/JVI.72.7.5648-5653.1998.

Abstract

DNA vaccination is an effective means of eliciting both humoral and cellular immunity, including cytotoxic T lymphocytes (CTL). Using an influenza virus model, we previously demonstrated that injection of DNA encoding influenza virus nucleoprotein (NP) induced major histocompatibility complex class I-restricted CTL and cross-strain protection from lethal virus challenge in mice (J. B. Ulmer et al., Science 259:1745-1749, 1993). In the present study, we have characterized in more detail the cellular immune responses induced by NP DNA, which included robust lymphoproliferation and Th1-type cytokine secretion (high levels of gamma interferon and interleukin-2 [IL-2], with little IL-4 or IL-10) in response to antigen-specific restimulation of splenocytes in vitro. These responses were mediated by CD4+ T cells, as shown by in vitro depletion of T-cell subsets. Taken together, these results indicate that immunization with NP DNA primes both cytolytic CD8+ T cells and cytokine-secreting CD4+ T cells. Further, we demonstrate by adoptive transfer and in vivo depletion of T-cell subsets that both of these types of T cells act as effectors in protective immunity against influenza virus challenge conferred by NP DNA.

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Female
  • Influenza Vaccines / immunology*
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Nucleocapsid Proteins
  • Nucleoproteins*
  • Vaccination
  • Vaccines, DNA / immunology*
  • Viral Core Proteins / genetics*
  • Viral Core Proteins / immunology

Substances

  • Influenza Vaccines
  • Nucleocapsid Proteins
  • Nucleoproteins
  • Vaccines, DNA
  • Viral Core Proteins